Xencor xencor.com


Public list: BIO 2016 (619) Synthetic Biology (152) Pharma Startups (4740) Cancer Therapeutics (1146)

Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency. The company is advancing multiple XmAb antibody drug candidates in the clinic, including XmAb5871 targeting CD32b and CD19 for autoimmune diseases, and an anti-CD30 candidate XmAb2513 for the treatment of Hodgkin's lymphoma. Xencor is also advancing a portfolio of biosu...Show all

Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency. The company is advan...Show all

Company (IPO / Went public)

Phone: 626-305-5900

Fax:

111 West Lemon Ave

Monrovia, 91016
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Xencor $229.9M Dec 3, 2013
Molecular Templates $41.9M Mar 17, 2017
PlantForm Corporation $0M Mar 20, 2019
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Xencor Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors

Competitors

Company Status Description Investors
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Nucleic acids encoding complement component c5 antibodies Jul 10, 2017 Apr 03, 2018 Patent
Methods and compositions for inhibiting cd32b expressing cells Jul 10, 2014 Mar 13, 2018 Patent
Methods and compositions for inhibiting cd32b expressing cells Jul 10, 2014 Feb 27, 2018 Patent
Heterodimeric antibodies to cd3 x cd123 Jun 17, 2016 Jan 02, 2018 Patent
Heterodimeric antibodies to cd3 x cd20 Jun 17, 2016 Dec 26, 2017 Patent
See all 139 patents